Close Notification

Your cart does not contain any items

Hacking the Code of Life

How gene editing will rewrite our futures

Nessa Carey



In stock
Ready to ship


Icon Books
18 August 2020
Series: Hot Science
'A focused snapshot of a brave new world.' - Nature In 2018 the world woke up to gene editing with a storm of controversy over twin girls born in China with genetic changes deliberately introduced by scientists - changes they will pass on to their own offspring.

Genetic modification (GM) has been with us for 45 years now, but the new system known as CRISPR or gene editing can manipulate the genes of almost any organism with a degree of precision, ease and speed that we could only dream of ten years ago.

But is it ethical to change the genetic material of organisms in a way that might be passed on to future generations? If a person is suffering from a lethal genetic disease, is it unethical to deny them this option? Who controls the application of this technology, when it makes 'biohacking' - perhaps of one's own genome - a real possibility?

Nessa Carey's book is a thrilling and timely snapshot of a cutting-edge technology that will radically alter our futures and the way we prevent disease.
By:   Nessa Carey
Imprint:   Icon Books
Country of Publication:   United Kingdom
Dimensions:   Height: 198mm,  Width: 129mm, 
ISBN:   9781785786259
ISBN 10:   1785786253
Series:   Hot Science
Pages:   192
Publication Date:   18 August 2020
Audience:   General/trade ,  ELT Advanced
Format:   Paperback
Publisher's Status:   Active

Nessa Carey worked in the biotech and pharma industry for thirteen years and is a Visiting Professor at Imperial College London. Her previous books for Icon are The Epigenetics Revolution (2011), described by The Guardian as 'a book that would have had Darwin swooning', and Junk DNA (2015), 'a cutting-edge guide to the ever-more mysterious genome' (New Scientist).

Reviews for Hacking the Code of Life: How gene editing will rewrite our futures

'Carey's trawl of potential applications - such as high-yield rice varieties, therapies for sickle-cell disease and germline gene editing - is edifying. A focused snapshot of a brave new world.' * Nature * '[A]n excellent, brisk guide to what is likely to happen as opposed to the fantastically remote.' * Los Angeles Review of Books * 'A brisk, accessible primer on the fast-moving field, a clear-eyed look at a technology that is already driving major scientific advances - and raising complex ethical questions.' -- Emily Anthes * Undark *

See Also